Dorsey Wright & Associates Cyma Bay Therapeutics, Inc. Transaction History

Dorsey Wright & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$10.86 - $17.62 $2,237 - $3,629	-206 Reduced 3.34%	5,956 $88,000
Q2 2023 Jul 26, 2023	BUY	$7.47 - $10.95 $4,594 - $6,734	615 Added 11.09%	6,162 $67,000
Q1 2023 Apr 19, 2023	SELL	$5.88 - $9.59 $3,616 - $5,897	-615 Reduced 9.98%	5,547 $48,000
Q4 2022 Feb 14, 2023	BUY	$3.22 - $6.27 $19,841 - $38,635	6,162 New	6,162 $38,000

1.82M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.